PHILLIPS 66 DL-,01/ US7185461040 /
2024-08-31 9:42:33 AM | Chg. 0.00 | Volume | Bid9:42:33 AM | Ask9:42:33 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
126.26EUR | 0.00% | - Turnover: - |
126.26Bid Size: - | 128.30Ask Size: - | 53.16 bill.EUR | - | - |
GlobeNewswire
08-20
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage wi...
GlobeNewswire
08-16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
08-15
NobleAI to Present at American Chemical Society’s Fall Conference, “Elevating Chemistry”
GlobeNewswire
08-14
Mountain America Credit Union Achieves Top National Ranking for Business Deposits
GlobeNewswire
08-14
Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
08-13
The American Fuel & Petrochemical Association Recognizes BrandSafway with 44 Awards
GlobeNewswire
08-08
EyePoint Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conferen...
GlobeNewswire
08-01
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Dire...
GlobeNewswire
08-01
H&R Block Offers Free Mid-Year Check-In to Help Tax Filers Maximize Refunds, Avoid Tax Season Surpri...
GlobeNewswire
07-31
Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latigl...
GlobeNewswire
07-30
Superposition Labs Unveils MovePosition: Redefining Decentralized Finance with Adaptive Risk Managem...
GlobeNewswire
07-29
Technip Energies awarded a proprietary equipment contract by Chevron Phillips Chemical for the first...
GlobeNewswire
07-25
Phillips Edison & Company Reports Second Quarter 2024 Results and Reaffirms Full Year Earnings Guida...
GlobeNewswire
07-25
Phillips Edison & Company Acquires Grocery-Anchored Shopping Center in Partnership with Cohen & Stee...
GlobeNewswire
07-19
CrossAmerica Partners to Announce Second Quarter 2024 Earnings Results on August 7
GlobeNewswire
07-16
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for...